CD8A and neoplasm: ICI therapy shows limited anti-tumor activity in PCa,[65,66] partly due to the poor infiltration of immune components in the TME.[67] For example, Ford et al[68] revealed that CAFs promoted the exclusion of CD8+ T cells from tumors and induced an immunosuppressive TME.